For the latest media releases and news about Pharmaxis Ltd, please select from the following articles. Material news announcements made by Pharmaxis are first filed with the Australian Securities Exchange (ASX) and are also available on the ASX website.
Pharmaceutical company Pharmaxis (ASX: PXS) today announced the appointment of experienced international pharmaceutical executive Dr Simon Buckingham, to its Board of Directors. Dr Buckingham has more than 20 years experience in top tier pharmaceutical and biotechnology companies with expertise in general management, sales and marketing, clinical development, business development and corporate strategic planning.
Read full media release - pdf